Revolutionizing Drug R&D with Human-Relevant Methodologies & Artificial Intelligence
In the United States alone, COVID-19 erased two decades of life expectancy growth. The U.S. also ranks lowest in life expectancy for both men and women among countries with high GDP per capita. With a 90-95% average failure rate for drug candidates in the U.S., a 10-15 year average timeline for a drug to receive […]
A Review of Human Disease Models in Drug Development
In the article Human disease models in drug development published in Nature, the authors delve into the critical role of human disease models in drug development, emphasizing the importance of bridging the gap between bench and bedside. They shed light on the challenges and opportunities associated with leveraging human disease models to accelerate the discovery […]
The Milieu of Zuzalu
The sun began its slow descent into the Adriatic Sea when we arrived in Montenegro on May 2, 2023. Picture a 2-month long (non) Burning Man off the glittering coast celebrated by futurists in the fields of longevity, cryptocurrency, AI, and The Network State. That was the phenomenon that was Zuzalu. Originally conceived by Vitalik […]